Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy

被引：2
作者：
Fyfe I.
机构：
来源：
Nature Reviews Neurology | 2016年 / 12卷 / 7期
关键词：
D O I：
10.1038/nrneurol.2016.76
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：372 / 372
相关论文
共 50 条
  • [31] The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis
    Claflin, Suzi B.
    Campbell, Julie A.
    Mason, Deborah F.
    Kalincik, Tomas
    Simpson-Yap, Steve
    Norman, Richard
    Butzkueven, Helmut
    Carroll, William M.
    Palmer, Andrew J.
    Blizzard, C. Leigh
    van der Mei, Ingrid
    Taylor, Bruce, V
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (05) : 831 - 841
  • [32] Comparative Efficacy of Disease-Modifying Treatments for Relapsing Multiple Sclerosis-Variations in Real-World Experience
    Wolf, Andrew B.
    Alvarez, Enrique
    Corboy, John R.
    JAMA NEUROLOGY, 2024, 81 (01) : 87 - 87
  • [33] Multiple sclerosis disease-modifying therapy and pregnancy
    Miller, Aaron E.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : 715 - 716
  • [34] Prevalence of adverse events with long-term disease-modifying therapy and their impact on quality of life in patients with multiple sclerosis
    Oztekin, N.
    Oztekin, M. F.
    Eruyar, E.
    Bilen, S.
    Ak, F.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 415 - 416
  • [35] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
    Tanuja Chitnis
    Neurotherapeutics, 2013, 10 : 89 - 96
  • [36] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
    Chitnis, Tanuja
    NEUROTHERAPEUTICS, 2013, 10 (01) : 89 - 96
  • [37] Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis
    Choudhary, Aditya
    Vinny, Wilson Pulikottil
    JAMA NEUROLOGY, 2016, 73 (04) : 480 - 480
  • [38] EMERGENCY ROOM UTILIZATION AMONG MULTIPLE SCLEROSIS PATIENTS TREATED WITH DISEASE-MODIFYING THERAPY IN A REAL-WORLD HYBRID CLAIMS DATABASE
    Kuranz, S.
    VALUE IN HEALTH, 2024, 27 (06) : S215 - S215
  • [39] Impact of adherence to disease modifying therapies on long-term clinical and economic outcomes in multiple sclerosis: A claims analysis of real-world data
    Amezcua, Lilyana
    Livingston, Terrie
    Hayward, Brooke
    Zhou, Jia
    Williams, Mitzi J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 77
  • [40] Comparative effectiveness of long-term users of disease-modifying therapy
    Salter, A.
    Tang, Y.
    Hornung, L.
    Kolodny, S.
    Hurtukova, D.
    Glenski, S.
    Cofield, S.
    Zhang, X.
    Cutter, G.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 309 - 310
12345